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Abstract
Background: To report a 45 year old lady presenting with proximal jejunal gangrene due to
invasive Aspergillosis. The patient was undergoing adjuvant chemotherapy for advance carcinoma
of breast (Stage IV).
Methods: The patient was referred to our surgical emergency for acute abdominal symptoms for
6 hours. Histopathology revealed bowel wall necrosis and vascular invasion by Aspergillus
Fumigatus. Postoperative recovery was uneventful and the patient received Amphotericin-B (1 mg/
kg/day) for invasive aspergillosis. Invasive pulmonary aspergillosis was confirmed by isolating
Aspergillus Fumigatus from bronchoalveolar lavage and by a positive circulating galactomannan test
(ELISA Assay).
Results: Detailed history revealed dry cough and two episodes of haemoptesis for 2 weeks.
Haemogram and counts revealed anemia and neutropenia. Plain X – ray of the abdomen showed
multiple air fluid levels and ultrasound of the abdomen revealed distended bowel loops. On
exploration small bowel was found to be gangrenous. The patient was successfully managed by
supportive treatment and conventional intravenous Amphotericin-B for 2 weeks. The lady was
discharged one week after completion of antifungal therapy and one month later she underwent
toilet mastectomy. The lady came to follow up for 1 year and she is currently under hormone
therapy.
Conclusion: With the emergence of new and powerful immunosuppressive, anticancer drugs and
potent antibiotics the survival of transplant and critically ill patients has remarkably increased but
it has shown a significant rise in the incidence of invasive opportunistic fungal infections. We
conclude hat the diagnosis of invasive gastrointestinal aspergillosis may be considered in a
neutropenic patient with acute abdominal symptoms.
Background
Despite the use of new and effective drugs, the dissemi-
nated invasive aspergillosis often remains lethal in neu-
tropenic patients [1]. There is a great need to create high
index of clinical investigation and develop better diagnos-
tic tools to detect invasive aspergillosis before it causes
irreversible damage. In the present study we report a 45
year old lady with severe neutropenia (400/cumm) pre-
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senting with acute abdomen. Invasive gastrointestinal
aspergillosis leading to widespread proximal bowel inf-
arction was found on exploration. The diagnosis was
established by isolating Aspergillus fumigatus from bron-
choalveolar lavage and by a positive circulating galacto-
mannan test (ELISA). The patient received conventional
intravenous amphotericin-B for 2 weeks.
Methods
A 45 year old lady admitted in intensive care unit was
referred to our surgical emergency unit for severe acute
pain and distention of the abdomen for 6 hours. She was
undergoing chemotherapy in clinical oncology depart-
ment for locally advance carcinoma (Stage IV) of breast
and four days back she was shifted to the intensive care
unit when she developed severe neutropenia after fourth
cycle CAF regimen (Cyclophosphamide 500 mg/m2, Adri-
amycin 50 mg/m2 and 5-FU 500 mg/m2). There was no
metastasis. Detailed history revealed that the patient had
developed dry cough and fever 7 days back. The patient
had absolute constipation. On examination the abdomen
was distended and there was guarding and rebound ten-
derness. Hematocrit and counts revealed anemia (Hb 7
gm%) and neutropenia (400/cumm).
Plain radiograph of chest showed patchy infiltrates in
both the lung fields suggestive of pneumonitis and X-ray
abdomen showed distended bowel loops and multiple air
fluid levels. There was no gas under the diaphragm. Ultra-
sound of the abdomen could not add much to the find-
ings of plain X-ray and showed distended bowel loops
and minimal interbowel fluid. Emergency exploratory
laprotomy was performed under general anesthesia.
About 30 cm of proximal jejunum 15 cm distal to duo-
deno-jejunal junction was found to be gangrenous. Pri-
mary resection and anastomosis was done and the
specimen (resected bowel segment with adjoining mesen-
tery) was sent for histopathology. After surgery the patient
was shifted to postoperative ICU where she developed
fever which was not responding to any antibiotic.
On the basis of preoperative X-ray chest, neutropenia and
high index of clinical suspicion broncho-alveolar lavage
was performed which revealed pulmonary aspergillosis.
Serum galactomannan test (ELISA) was also positive for
Aspergillus. The diagnosis of invasive pulmonary aspergil-
losis was made and the patient was put on conventional
intravenous Amphotericin B (1 mg/kg/day) for 2 weeks.
Histopathology of the specimen was available on fourth
postoperative day and revealed transmural ischemic
necrosis of the bowel and widespread invasion and block-
ade of arterioles due to Aspergillus fungal forms (Fig. 1).
The diagnosis of invasive gastrointestinal aspergillosis sec-
ondary to pulmonary Aspergillosis was made and antifun-
gal treatment was continued. The patient responded to
intravenous antifungal treatment and was discharged after
2 week of antifungal treatment. The lady underwent toilet
mastectomy and was under follow up for 1 year. Postop-
erative chemotherapy was also given after improvements
in the counts and presently she is under hormone therapy.
Results and discussion
In our patient the diagnosis was made by exclusion and
the decision for bronchi-alveolar lavage was taken which
came out positive for aspergillosis. This evidence along
with positive galactomannan test was enough to support
the diagnosis of invasive Aspergillosis and intravenous
Amphotericin B was started. The patient showed dramatic
response and fever subsided on the next day. After recov-
ery patient underwent modified radical mastectomy and
postoperative chemotherapy and hormone therapy were
also given. The patient was alive and well at the end of 1
year follow up.
Invasive gastrointestinal aspergillosis is an opportunistic
infection that characteristically affects the immunocom-
promised host, resulting in high degree of morbidity and
mortality [2]. The incidence of invasive aspergillosis has
risen considerably during the past decade due to more
intensive chemotherapy, organ transplantation, intensive
care, and aggressive surgical interventions [3]. Extrapul-
monary aspergillosis is rare but can involve gastrointesti-
nal tract, heart, kidney, central nervous system, liver and
pancreas etc [4]. Almost one-quarter of those with inva-
sive pulmonary aspergillosis develop disseminated infec-
tion with Aspergillus sp. via hematogenous spread [2,5].
Among these patients the reported incidence of gastroin-
testinal involvement has been 41 – 47% [2,5,6].
Patients with bowel involvement are rarely diagnosed
prior to autopsy because the typical symptoms of abdom-
inal pain, obstruction and gastrointestinal bleeding are
usually overshadowed by the septic manifestation of sys-
temic infection. Wingrad et al [7] documented a case of
aspergillosis as an unusual cause of perforated appendici-
tis in 1982. In our patient gastrointestinal invasion was
secondary to hematogenous spread of fungal forms lead-
ing to ischemic necrosis of bowel. The diagnosis was made
on the basis of high clinical suspicion followed by bron-
choalveolar lavage and positive serum galactomannan
test. This diagnosis should be considered when a neutro-
penic patients presents with abdominal pain and disten-
tion with fever.
There has been an increased understanding of the immu-
nology of Aspergillus infection, paving the way to novel
immune augmentation strategies in animal models that
merit evaluation in phase I clinical trials [8]. Chest CT
scan [8] and new techniques like PCR assays based on real
time technologies that are able to quantify AspergillusJournal of Carcinogenesis 2006, 5:18 http://www.carcinogenesis.com/content/5/1/18
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DNA are promising [9]. Considerable progress has been
made in understanding the genetics of Aspergillus Fumi-
gates and molecular techniques for manipulation of the
fungus have been developed but still invasive Aspergillus's
is associated with a high mortality rate ranging from 30%
to 90% [10].
Repeated serum assays to detect Aspergillus antigenemia
and meticulous search for other aspergillosis localizations
like pulmonary, should continue until the diagnosis
allows administration of early antifungal therapy. Though
in our patient we used conventional antifungal treatment,
combined antifungal therapy or treatment with ampho-
tericin-B at high doses significantly reduces mortality as
compared with the conventional treatment [11].
Conclusion
Even with more effective and safer therapies, substantial
progress in quelling aspergillosis may not occur until the
early diagnostic tools are developed and incorporated
into strategies to start earlier treatment. We suggest that a
very high index of suspicion of invasive gastrointestinal
aspergillosis may be maintained in immunocompro-
mised patients presenting with acute abdominal symp-
toms.
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Histopathology analysis demonstrates vascular invasion by disseminated aspergillosis Figure 1
Histopathology analysis demonstrates vascular invasion by disseminated aspergillosis. (Arrows showing fungal forms).Publish with BioMed Central    and   every 
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